News Focus
News Focus
Replies to #20246 on Biotech Values
icon url

terry hallinan

12/12/05 1:08 PM

#20254 RE: DewDiligence #20246

DewDiligence - PTIE CC,

I thought the only worthwhile comment from the CC was the observation that developing drugs for conditions such as IBS that lack a preclinical model is a bad business to be in.

I fear you are exactly right.

IBS is a bummer - whatever it is.

Best, Terry